c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014). (Q38492604)

3 September 2017

1 reference

title

c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014). (English)

1 reference

3 September 2017

Matthias Gehringer

1

0 references

Stefan Laufer

object named as

Stefan A Laufer

series ordinal

4

0 references

author name string

Felix Muth

series ordinal

2

1 reference

3 September 2017

Pierre Koch

series ordinal

3

1 reference

3 September 2017

language of work or name

English

0 references

publication date

19 May 2015

1 reference

Expert Opinion on Therapeutic Patents

3 September 2017

published in

1 reference

3 September 2017

volume

25

1 reference

3 September 2017

issue

8

1 reference

3 September 2017

page(s)

849-872

1 reference

Therapeutic protein kinase inhibitors

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

JNK pathway: diseases and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Signal integration by JNK and p38 MAPK pathways in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

A mammalian scaffold complex that selectively mediates MAP kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Inhibitors of c-Jun N-terminal kinases: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

The protein kinase complement of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

JNK inhibitors as anti-inflammatory and neuroprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Implication of the JNK pathway in a rat model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Jun N-Terminal Kinase/Stress-Activated Protein Kinase (JNK/SAPK) Is Required for Lipopolysaccharide Stimulation of Tumor Necrosis Factor Alpha (TNF-α) Translation: Glucocorticoids Inhibit TNF-α Translation by Blocking JNK/SAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

JNK-1 deficiency limits macrophage-mediated antigen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

The Role of JNK Proteins in Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

JNK signalling in cancer: in need of new, smarter therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

A small molecule-kinase interaction map for clinical kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Small molecule JNK (c-Jun N-terminal kinase) inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Design and Characterization of a Potent and Selective Dual ATP- and Substrate-Competitive Subnanomolar Bidentate c-Jun N-Terminal Kinase (JNK) Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Identification of an Adamantyl Azaquinolone JNK Selective Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Design and synthesis of highly potent and isoform selective JNK3 inhibitors: SAR studies on aminopyrazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Novel hinge-binding motifs for Janus kinase 3 inhibitors: a comprehensive structure-activity relationship study on tofacitinib bioisosteres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

A public-private partnership to unlock the untargeted kinome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Synthesis, Biological Evaluation, X-ray Structure, and Pharmacokinetics of Aminopyrimidine c-jun-N-terminal Kinase (JNK) Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Design, synthesis, and structure–activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

The resurgence of covalent drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

X-ray crystal structure of JNK2 complexed with the p38alpha inhibitor BIRB796: insights into the rational design of DFG-out binding MAP kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Protein kinases: evolution of dynamic regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

The DLK signalling pathway--a double-edged sword in neural development and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543776.2015.1039984

10.1517/13543776.2015.1039984

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference